These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29348660)

  • 1. Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.
    Mathew JM; Voss JH; McEwen ST; Konieczna I; Chakraborty A; Huang X; He J; Gallon L; Kornbluth RS; Leventhal JR
    Sci Rep; 2018 Jan; 8(1):1136. PubMed ID: 29348660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells.
    Garg G; Nikolouli E; Hardtke-Wolenski M; Toker A; Ohkura N; Beckstette M; Miyao T; Geffers R; Floess S; Gerdes N; Lutgens E; Osterloh A; Hori S; Sakaguchi S; Jaeckel E; Huehn J
    Oncotarget; 2017 May; 8(22):35542-35557. PubMed ID: 28415767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance.
    Nagahama K; Fehervari Z; Oida T; Yamaguchi T; Ogawa O; Sakaguchi S
    Int Immunol; 2009 Apr; 21(4):379-91. PubMed ID: 19228878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
    Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
    Front Immunol; 2021; 12():686530. PubMed ID: 34777330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
    J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.
    Schoenbrunn A; Frentsch M; Kohler S; Keye J; Dooms H; Moewes B; Dong J; Loddenkemper C; Sieper J; Wu P; Romagnani C; Matzmohr N; Thiel A
    J Immunol; 2012 Dec; 189(12):5985-94. PubMed ID: 23162126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.
    Albert MH; Yu XZ; Magg T
    Clin Immunol; 2008 Dec; 129(3):381-93. PubMed ID: 18819845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
    Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
    Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation.
    Nafady-Hego H; Li Y; Ohe H; Elgendy H; Zhao X; Sakaguchi S; Bishop GA; Koshiba T
    Transpl Immunol; 2016 May; 36():1-8. PubMed ID: 27105585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.
    Ford McIntyre MS; Gao JF; Li X; Naeini BM; Zhang L
    Int Immunopharmacol; 2011 May; 11(5):597-603. PubMed ID: 21109036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood.
    Fan H; Yang J; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Gao F; Liu M
    Immunology; 2012 Jun; 136(2):218-30. PubMed ID: 22348606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of
    Lee LM; Zhang H; Lee K; Liang H; Merleev A; Vincenti F; Maverakis E; Thomson AW; Tang Q
    Front Immunol; 2021; 12():679675. PubMed ID: 34220826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40L-stimulated B cells for ex-vivo expansion of polyspecific non-human primate regulatory T cells for translational studies.
    Alonso-Guallart P; Llore N; Lopes E; Kofman SB; Ho SH; Stern J; Pierre G; Bruestle K; Tang Q; Sykes M; Griesemer A
    Clin Exp Immunol; 2021 Mar; 203(3):480-492. PubMed ID: 33058141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.